These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33668946)

  • 1. HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China.
    Li M; Liang S; Zhou C; Chen M; Liang S; Liu C; Zuo Z; Liu L; Feng Y; Song C; Xing H; Ruan Y; Shao Y; Liao L
    Pathogens; 2021 Feb; 10(3):. PubMed ID: 33668946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    Xie YN; Zhu FX; Zhong YT; Chen YT; Gao Q; Lai XL; Liu JJ; Huang DD; Zhang YN; Chen X
    J Antimicrob Chemother; 2021 Oct; 76(11):2975-2982. PubMed ID: 34402512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic landscape for majority and minority HIV-1 drug resistance mutations in antiretroviral therapy naive patients in Accra, Ghana.
    Appiah P; Gbassana G; Adusei-Poku M; Obeng BM; Duedu KO; Sagoe KWC
    Heliyon; 2024 Jun; 10(12):e33180. PubMed ID: 39022058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shall I trust the report? Variable performance of Sanger sequencing revealed by deep sequencing on HIV drug resistance mutation detection.
    Chen NY; Kao SW; Liu ZH; Wu TS; Tsai CL; Lin HH; Wong WW; Chang YY; Chen SS; Ku SW
    Int J Infect Dis; 2020 Apr; 93():182-191. PubMed ID: 32061862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya.
    Beck IA; Levine M; McGrath CJ; Bii S; Milne RS; Kingoo JM; So I; Andersen N; Dross S; Coombs RW; Kiarie J; Chohan B; Sakr SR; Chung MH; Frenkel LM
    EClinicalMedicine; 2020 Jan; 18():100239. PubMed ID: 31956856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
    Silver N; Paynter M; McAllister G; Atchley M; Sayir C; Short J; Winner D; Alouani DJ; Sharkey FH; Bergefall K; Templeton K; Carrington D; Quiñones-Mateu ME
    AIDS Res Ther; 2018 Nov; 15(1):18. PubMed ID: 30409215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.
    Milne RS; Silverman RA; Beck IA; Mckernan-Mullin J; Deng W; Sibley TR; Dross S; Kiarie JN; Sakr SR; Coombs RW; Chung MH; Frenkel LM
    AIDS; 2019 May; 33(6):941-951. PubMed ID: 30946148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study.
    Adawaye C; Fokam J; Kamangu E; Alio HM; Chahad AM; Susin F; Moussa AM; Bertin TH; Tidjani A; Vaira D; Moutschen M
    BMC Res Notes; 2017 Nov; 10(1):589. PubMed ID: 29126456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV-1 Drug Resistance among Patients with Antiretroviral Therapy Failure in Sichuan, China, 2010-2016.
    Dong K; Ye L; Leng Y; Liang S; Feng L; Yang H; Su L; Li Y; Baloch S; He F; Yuan D; Pei X
    Tohoku J Exp Med; 2019 Jan; 247(1):1-12. PubMed ID: 30643108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
    Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
    BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.
    Metzner KJ; Leemann C; Di Giallonardo F; Grube C; Scherrer AU; Braun D; Kuster H; Weber R; Guenthard HF
    PLoS One; 2011; 6(7):e21734. PubMed ID: 21754996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-resistance characteristics of CRF01_AE and CRF07_BC subtypes of HIV-1 strains in Sichuan province].
    Yuan D; Su L; Liu H; Yu H; Yang H; Ye L; Wei D; Pei X; Liang S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Oct; 49(10):901-6. PubMed ID: 26813724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
    Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure.
    Mohamed S; Penaranda G; Gonzalez D; Camus C; Khiri H; Boulmé R; Sayada C; Philibert P; Olive D; Halfon P
    AIDS; 2014 Jun; 28(9):1315-24. PubMed ID: 24698843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
    Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
    Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
    Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
    PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug resistance and virological failure in children.
    Gopalan BP; D'Souza RR; Rajnala N; Arumugam K; Dias M; Ranga U; Shet A
    J Med Virol; 2019 Jun; 91(6):1036-1047. PubMed ID: 30695102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
    Ávila-Ríos S; García-Morales C; Matías-Florentino M; Romero-Mora KA; Tapia-Trejo D; Quiroz-Morales VS; Reyes-Gopar H; Ji H; Sandstrom P; Casillas-Rodríguez J; Sierra-Madero J; León-Juárez EA; Valenzuela-Lara M; Magis-Rodríguez C; Uribe-Zuñiga P; Reyes-Terán G;
    Lancet HIV; 2016 Dec; 3(12):e579-e591. PubMed ID: 27658867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.